GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.

Following Pfizer's disposal, BlackRock Investment Management (UK) Ltd, a unit of BlackRock, will become Haleon's largest ...

Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and ...

I initiate coverage on Haleon with a "hold" rating due to decent results and potential for ongoing growth, despite a slight revenue slip last year. Haleon's dividend grew 10% and is well-covered ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

Kefir, a probiotic-rich fermented milk, shows potential in reducing neuroinflammation, oxidative stress, and beta-amyloid ...

The antiaging movement has raced ahead amid fierce debates over even its earliest theories. Critics of a grandfather of the ...

27,396 Dental Screenings completed in 1 Day at Maha Kumbh World Oral Health Day campaign will educate people on the importance of good oral health & ensure better understanding through a free ...

India's drugmakers saw healthy revenue growth across all therapies in February as they debuted new drugs and raised prices, an industry report showed. Sales in the domestic pharmaceutical market ...

Founded in 2021 by Jatan Bawa and Tushar Khurana, Perfora aims to disrupt the stagnant oral hygiene market with clean, ...

The European Union is in short supply of 16 medicines that are considered “critical” for people’s health. A drug can be put on the EU’s shortages list because of production issues, a surge ...